Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

97.09
Delayed Data
As of Aug 26
 +0.71 / +0.74%
Today’s Change
75.90
Today|||52-Week Range
136.97
-22.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.5B1.2B580.4M1.0B
 
 
 
 
 
Cost of Goods Sold241.7M81.9M61.0M62.2M
 
 
 
 
 
Depreciation And Amortization38.2M48.4M63.3M62.3M
 
 
 
 
 
 
Operating ExpensesGross Income1.2B1.1B456.2M907.8M
 
 
 
 
 
General Expenses1.2B1.3B1.1B1.4B
 
 
 
 
 
Research And Development806.2M918.8M855.5M995.9M
 
 
 
 
 
Total Operating Expenses1.5B1.4B1.2B1.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.2M-199.4M-641.5M-464.7M
 
 
 
 
 
Extraordinary Charge-1.8M-704.0M-79.9M-2.2M
 
 
 
 
 
Interest Expense On Debt16.7M22.7M72.9M84.2M
 
 
 
 
 
Other Expenses0.00-49.9M59.4M-6.7M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.4M-976.1M-734.9M-557.8M
 
 
 
 
 
Income Taxes-38.8M-288.6M-7.0M-30.4M
 
 
 
 
 
Minority Interest-55.9M-242.5M-4.2M-31.8M
 
 
 
 
 
Discontinued Operations0.000.00-912.0K0.00
 
 
Net Income-107.0M-445.0M-738.6M-556.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS211.9M224.9M235.3M241.3M
 
 
 
 
 
Shares To Calculate EPS Diluted211.9M224.9M235.3M241.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$1.98-$3.14-$2.31
 
 
 
 
 
EPS Diluted-$0.50-$1.98-$3.14-$2.31